Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts

被引:43
作者
Csete, M
Rodriguez, L
Wilcox, M
Chadalavada, S
机构
[1] Emory Univ, Sch Med, Res Labs, Program Neurosci,Dept Anesthesiol, Atlanta, GA 30322 USA
[2] Univ Michigan, Ctr Med, Taubman Ctr 2128B, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Literature Sci & Arts, Ann Arbor, MI 48109 USA
关键词
dopaminergic neurons; dopamine transporter; erythropoeitin; Parkinson's disease; tyrosine hydroxylase;
D O I
10.1016/j.neulet.2004.01.068
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Exogenous erythropoietin (EPO) is a potent neurotrophic factor in vivo, protective against neuronal death in animal models of brain ischemia and human stroke. To date, reports on the distribution of EPO receptor in brain suggest that it is expressed mostly on capillaries. This receptor pattern suggests an indirect effect of EPO on neurons. In these studies, we show that EPO receptor is abundantly expressed on adult dopaminergic neurons, suggesting a direct effect of EPO on neurons. Furthermore, we show that EPO mediates the classic neurotrophic effects of proliferation, differentiation and maintenance in a dopaminergic cell line. The biology of therapeutically administered EPO in brain is a function of its receptor distribution, and the neuronal expression of EPO receptor on adult CNS neurons is consistent with EPO's potent neurotrophic function in vivo. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:124 / 126
页数:3
相关论文
共 15 条
[1]  
Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO
[2]  
2-H
[3]   Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J].
Brines, ML ;
Ghezzi, P ;
Keenan, S ;
Agnello, D ;
de Lanerolle, NC ;
Cerami, C ;
Itri, LM ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10526-10531
[4]  
Campana WM, 1998, INT J MOL MED, V1, P235
[5]   Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus [J].
Chikuma, M ;
Masuda, S ;
Kobayashi, T ;
Nagao, M ;
Sasaki, R .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (06) :E1242-E1248
[6]   Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades [J].
Chong, ZZ ;
Kang, JQ ;
Maiese, K .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (05) :503-514
[7]   Immortalized dopamine neurons: A model to study neurotoxicity and neuroprotection [J].
Clarkson, ED ;
Edwards-Prasad, J ;
Freed, CR ;
Prasad, KN .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (02) :157-163
[8]   LOCALIZATION OF SPECIFIC ERYTHROPOIETIN BINDING-SITES IN DEFINED AREAS OF THE MOUSE-BRAIN [J].
DIGICAYLIOGLU, M ;
BICHET, S ;
MARTI, HH ;
WENGER, RH ;
RIVAS, LA ;
BAUER, C ;
GASSMANN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3717-3720
[9]   Erythropoietin therapy for acute stroke is both safe and beneficial [J].
Ehrenreich, H ;
Hasselblatt, M ;
Dembowski, C ;
Cepek, L ;
Lewczuk, P ;
Stiefel, M ;
Rustenbeck, HH ;
Breiter, N ;
Jacob, S ;
Knerlich, F ;
Bohn, M ;
Poser, W ;
Rüther, E ;
Kochen, M ;
Gefeller, O ;
Gleiter, C ;
Wessel, TC ;
De Ryck, M ;
Itri, L ;
Prange, H ;
Cerami, A ;
Brines, M ;
Sirén, AL .
MOLECULAR MEDICINE, 2002, 8 (08) :495-505
[10]   Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production [J].
Genc, S ;
Kuralay, F ;
Genc, K ;
Akhisaroglu, M ;
Fadiloglu, S ;
Yorukoglu, K ;
Fadiloglu, M ;
Gure, A .
NEUROSCIENCE LETTERS, 2001, 298 (02) :139-141